Investor Relations

WSA delivered organic revenue growth of 7% (5% reported) to EUR 2,465 million and reported EBITDA increased by 14% to EUR 480 million in the fiscal year 2022/23.

About us

Formed in 2019 through the merger of Sivantos and Widex, WS Audiology combines more than 140 years’ experience in pioneering the use of technology to help people with hearing loss access the sounds that make life wonderful. Our ambition - as a global leader - is to unlock human potential by making wonderful sound part of everyone’s life. We are active in more than 130 countries around the world. 

One out of three hearing aids worn globally is made by us. Our broad portfolio of leading hearing-related products and services generated annual revenues of € 2,351 million (2021/22). WS Audiology is privately owned by the Tøpholm and Westermann families, as well as funds under the management of EQT.

Your contact:
Go to the top